share_log

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

艾伯維公司 | 25-NSE：由交易所申報的註銷已到期、已贖回、已兌付證券的通知
美股sec公告 ·  05/17 21:07
牛牛AI助理已提取核心訊息
The New York Stock Exchange (NYSE) has officially notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of GRI BIO, Inc. This action is set to take place at the start of business on May 28, 2024, in accordance with Rule 12d2-2(a). The notification follows the redemption or full payment of the securities at maturity or retirement, which occurred on May 17, 2024. Consequently, trading of GRI BIO, Inc.'s securities was suspended on the NYSE as of May 17, 2024.
The New York Stock Exchange (NYSE) has officially notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of GRI BIO, Inc. This action is set to take place at the start of business on May 28, 2024, in accordance with Rule 12d2-2(a). The notification follows the redemption or full payment of the securities at maturity or retirement, which occurred on May 17, 2024. Consequently, trading of GRI BIO, Inc.'s securities was suspended on the NYSE as of May 17, 2024.
紐約證券交易所（NYSE）已正式通知美國證券交易委員會（SEC），它打算將GRI BIO, Inc.的全部類別證券除名。根據規則12d2-2 (a)，該行動定於2024年5月28日開始營業時進行。該通知是在2024年5月17日到期或退休時贖回或全額支付證券之後發出的。因此，GRI BIO, Inc.的交易s證券自2024年5月17日起在紐約證券交易所暫停發行。
紐約證券交易所（NYSE）已正式通知美國證券交易委員會（SEC），它打算將GRI BIO, Inc.的全部類別證券除名。根據規則12d2-2 (a)，該行動定於2024年5月28日開始營業時進行。該通知是在2024年5月17日到期或退休時贖回或全額支付證券之後發出的。因此，GRI BIO, Inc.的交易s證券自2024年5月17日起在紐約證券交易所暫停發行。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。